Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 20;26(6):439-448.
doi: 10.3779/j.issn.1009-3419.2023.102.22.

[Incidence and Risk Factors of Venous Thromboembolism in Patients with Lung Adenocarcinoma Receiving Anti-tumor Therapy]

[Article in Chinese]
Xing Chen  1 , Weiping Xie  1 , Chaoli Yue  1 , Ting Tang  1 , Yuchuyuan Sun  1 , Kouying Liu  1
Affiliations

[Incidence and Risk Factors of Venous Thromboembolism in Patients with Lung Adenocarcinoma Receiving Anti-tumor Therapy]

[Article in Chinese]
Xing Chen et al. Zhongguo Fei Ai Za Zhi. .

Abstract
in English, Chinese

Background: Venous thromboembolism (VTE) as the most common cancer-associated complication has become the second death-causing reason among cancer patients. The management of VTE in patients with lung adenocarcinoma should focus on early and timely detection of risk factors. The aim of the study is to investigate the current situation of VTE in patients with lung adenocarcinoma treated with anti-tumor therapy and then explore the risk factors associated with the occurrence of VTE during anti-tumor therapy for early detection and screening of VTE.

Methods: The present study included patients diagnosed as lung adenocarcinoma undergoing anti-tumor therapy in First Affiliated Hospital of Nanjing Medical University between December 2019 and May 2021. The risk factors were identified via univariate and multivariate Cox analysis. The incidence of independent risk factors were investigated through Kaplan-Meier curves combined with Log-rank test.

Results: The results of univariate and multivariate Cox regression showed that history of VTE, targeted therapy and radiotherapy were risk factors for VTE in patients with lung adenocarcinoma treated with anti-tumor therapy (P<0.05). Furthermore, the results of Kaplan-Meier curves and Log-rank tests indicated the incidences of VTE in patients with history of VTE, targeted therapy and radiotherapy were higher (P<0.05).

Conclusions: History of VTE, radiotherapy and targeted therapy are found as independent risk factors for the occurrence of VTE, which should be identified and monitored for reduction of VTE incidence. .

【中文题目：抗肿瘤治疗的肺腺癌患者发生静脉血栓栓塞的情况及危险因素分析】 【中文摘要：背景与目的 静脉血栓栓塞（venous thromboembolism, VTE）是癌症患者最常见的并发症，也是癌症患者死亡的第二大原因。肺腺癌患者发生VTE的管理重点在于早期、及时发现危险因素。本研究旨在调查抗肿瘤治疗的肺腺癌患者VTE发生现状，探讨在抗肿瘤治疗过程中发生VTE的影响因素，为VTE的早期识别和筛查提供依据。方法 收集2019年12月-2021年5月于南京医科大学第一附属医院确诊为肺腺癌且行抗肿瘤治疗患者的临床资料，分别采用Cox单因素及多因素回归分析、Kaplan-Meier曲线和Log-rank检验比较独立危险因素影响VTE发生的差异。结果 Cox回归单因素及多因素分析显示，VTE病史、靶向药物治疗、放疗是抗肿瘤治疗肺腺癌患者VTE发生的危险因素（P<0.05）。Kaplan-Meier曲线和Log-rank检验比较独立危险因素发现VTE病史、靶向治疗、放疗患者的VTE发生率更高（P<0.05）。结论 有VTE病史、放疗、靶向治疗是VTE发生的高危因素，对于这类影响因素的早期识别和筛查有助于今后临床实践中VTE的防控和管理。 】 【中文关键词：肺肿瘤；静脉血栓栓塞；抗肿瘤治疗；影响因素】.

Keywords: Antitumor therapy; Lung neoplasms; Risk factors; Venous thromboembolism.

PubMed Disclaimer

Figures

Fig 1
图1. VTE病史患者与非VTE病史患者发生VTE的发生率曲线
Fig 2
图2. 进行放疗的患者与未进行放疗的患者发生VTE的发生率曲线
Fig 3
图3. 使用靶向药物治疗的患者与未使用靶向药物治疗的患者发生VTE的发生率曲线
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Gervaso L, Dave H, Khorana AA. . Venous and arterial thromboembolism in patients with cancer: JACC: cardiooncology state-of-the-art review. JACC CardioOncol, 2021, 3(2): 173-190. doi: 10.1016/j.jaccao.2021.03.001 - DOI - PMC - PubMed
    1. Farge D, Frere C, Connors JM, et al. . 2022. international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19. Lancet Oncol, 2022, 23(7): e334-e347. doi: 10.1016/S1470- 2045(22) 00160-7 - PMC - PubMed
    1. Lyman GH, Kuderer NM. . Clinical practice guidelines for the treatment and prevention of cancer-associated thrombosis. Thromb Res, 2020, 191 Suppl 1: S79-S84. doi: 10.1016/S0049-3848(20)30402-3 - DOI - PubMed
    1. Brown C, Brandt W, Wang TF, et al. . Incidence of recurrent venous thromboembolism and bleeding complications in patients with cancer and isolated distal deep vein thrombosis. Thromb Res, 2023, 228: 81-84. doi: 10.1016/j.thromres.2023.05.027 - DOI - PubMed
    1. Li TT, Shi LC, Kong H, et al. . Risk factors and predictive efficacy of adenocarcinoma of the lung complicated with venous thromboembolism. Shandong Yiyao, 2021, 61(18): 84-87.
    2. [李甜甜, 石莉程, 孔辉, et al. . . 肺腺癌并发静脉血栓栓塞症的危险因素及其预测效能. 山东医药, 2021, 61(18): 84-87.] doi: 1002-266X(2021)18-0084-04

Publication types